PRUVN’s Post

#ICYMI: MedTech Strategist/Market Pathways's own Stephen Levin will be moderating the "Successfully Navigating Exits and Financings in Tough Times" panel discussion between Earlybird Venture Capital's Dr. Christoph Massner and LimFlow SA's Dan Rose at MedTech Europe's The MedTech Forum 2024 on Thursday, May 23 at 10:40AM-11:30AM. Despite a challenging environment for M&A and fundraising amidst an evolving EU regulatory landscape, this panel features strategics, investors and start-up CEOs who are doing deals in spite of these obstacles, and are here to share their strategies in achieving these goals. Lean more here: https://lnkd.in/ex3Y9ySx #MTF2024 #conferences #paneldiscussion #medtech #medtechindustry #medtechinnovation #regulatory

How can fund managers generate real value in the current bear market? While the global economy shows signs of recovery, the narrative I'm still hearing is that MedTech-focused VCs are grappling with reduced funding, and a shift from early-stage agreements. But, we know from recent mega fund closures, like LAUXERA CAPITAL PARTNERS Capital and Fusion Fund, with the right attributes and skillsets, substantial value can still be generated for innovators. To unlock these fundraising strategies, Nick Ross, Henry Bell and I are delighted to be hosting our panel at LSI - Life Science Intelligence™ Europe 2023 Summit - “Game of Funds: How Fund Managers Are Levelling-Up to Raise From LPs And Create Value”. We'll be speaking to leading venture partners from across the MedTech space, to understand the pivotal role of value-driven decision-making when raising from LPs. Find out more about our full panel agenda here: https://lnkd.in/gBQF5wGa #lsieurope23, #funding #medtechinnovation #venturecapital

Previous Health Impact Investor Challenge winner UVX Inc discussed the Spring Investor Challenge and how it helped them amplify their impact. Want to see who wins this time around? Secure your spot at the finale Nimbus Synergies Health Impact Investor Challenge for TONIGHT: https://lu.ma/uehbryao Want to read more about UVX Inc? Head to our blog post here: https://hubs.ly/Q029PnqC0 #SpringIntoImpact #ImpactInvesting #HealthInnovation

What does BioStar Capital look for when investing? Hear it straight from Alan Davis, Managing Director. You can find the full discussion and more here: https://rb.gy/hkj8z2 #InvestorInsights #VentureCapital

Ready to make your mark in the MedTech world? Watch as McDermott + Bull's Ken Dropiewski and BioStar Capital's Alan Davis, MD unveil the keys to a successful pitch with investors. Learn how CEOs can gear up for a high-impact meeting with BioStar and what elements can make your presentation stand out. Unlock these insights and more in their full discussion: https://rb.gy/hkj8z2 #InvestorInsights #LifeSciences #MedTech #Investing #Finance #VentureCapital #VCsForCEOs #VCAdvice

Revisiting an outstanding 2023, #LSIAlumni raised more than $1.67 Billion in capital and closed 11 M&A transactions across 117+ total deals. Our new spreadsheet indexes these transactions, investors involved (publicly disclosed), and links to our proprietary media and coverage of the companies themselves. 🔗 Click here to see the 2023 LSI Alumni Funding Report: https://lnkd.in/gzSb_tKX We’ve received great feedback on this report from founders, VCs, strategics, and many other executives in Medtech and Healthtech, and look forward to publishing more resources on the news and stories of our growing global community. You’ll also see many of the alumni featured on this report at #LSIUSA24 this March. We’re less than 7 weeks away and have selected over 300 of the most exciting emerging companies in the industry to present to a full house of investors and strategics. Click the link above to see 117+ LSI Alumni deals from 2023.

Exciting News from NIMBLE Diagnostics! We are thrilled to announce that NIMBLE Diagnostics has been awarded the Best MedTech Startup of the Year by the #EIC! 🏆 A few weeks ago, our CEO Oriol Iborra showcased our WAEVE System at an ePitching competition among top MedTech startups recognized by the #EIC Accelerator. This recognition further validates our mission to introduce the world's first non-invasive technology for detecting defects in coronary stents, aiming to enhance care for #cardiovascular patients. Check out the post below to learn more and stay tuned for more exciting updates coming soon! #MedTechInnovation #HealthcareTechnology #EICAccelerator #CardiovascularHealth

A journey evolving in groundbreaking steps to mature interventional MRI to its designated course.

Geoff Meyerson of Locust Walk, shared insights with Chief Medical Officer 360º on 2024 fundraising and business development trends. Discover how CMOs can enhance investor interactions. Don't miss advice for biotechs & CMOs navigating financing complexities.    Read the full article for a comprehensive overview and strategic outlook: https://lnkd.in/eMWjGXU8    #BiotechTrends #FinancialOutlook #CMOStrategies #InvestorRelations 

Listen to our DNB//Back Bay representatives discuss the current landscape of IPO and capital markets, optimal preparation strategies for companies hoping to go public and why it matters who you spend your time with. #healthcare #ipo